These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7947388)

  • 21. c-fos promoter insensitivity to phorbol ester and possible role of protein kinase C in androgen-independent cancer cells.
    Krongrad A; Bai G
    Cancer Res; 1994 Dec; 54(23):6073-7. PubMed ID: 7954449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells.
    Powell CT; Brittis NJ; Stec D; Hug H; Heston WD; Fair WR
    Cell Growth Differ; 1996 Apr; 7(4):419-28. PubMed ID: 9052983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen.
    Miyake H; Hara I; Gleave ME; Eto H
    Prostate; 2004 Dec; 61(4):318-23. PubMed ID: 15389725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
    Jalava A; Akerman K; Heikkilä J
    J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway.
    Kim IY; Seong DH; Kim BC; Lee DK; Remaley AT; Leach F; Morton RA; Kim SJ
    Cancer Res; 2002 Jul; 62(13):3649-53. PubMed ID: 12097269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha.
    Gschwend JE; Fair WR; Powell CT
    Mol Pharmacol; 2000 Jun; 57(6):1224-34. PubMed ID: 10825394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fos and Jun form cell specific protein complexes at the neuropeptide tyrosine promoter.
    Jalava A; Mai S
    Oncogene; 1994 Aug; 9(8):2369-75. PubMed ID: 8036020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of chronic phorbol ester treatment on protein kinase C activity, content, and gene expression in the human monoblastoid U937 cell.
    Ways DK; Qin W; Garris TO; Chen J; Hao E; Cooper DR; Usala SJ; Parker PJ; Cook PP
    Cell Growth Differ; 1994 Feb; 5(2):161-9. PubMed ID: 8180129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway.
    Lee SO; Lou W; Johnson CS; Trump DL; Gao AC
    Prostate; 2004 Aug; 60(3):178-86. PubMed ID: 15176047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgens regulate protein kinase Cdelta transcription and modulate its apoptotic function in prostate cancer cells.
    Gavrielides MV; Gonzalez-Guerrico AM; Riobo NA; Kazanietz MG
    Cancer Res; 2006 Dec; 66(24):11792-801. PubMed ID: 17178875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer.
    Xie X; Zhao X; Liu Y; Zhang J; Matusik RJ; Slawin KM; Spencer DM
    Cancer Res; 2001 Sep; 61(18):6795-804. PubMed ID: 11559553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.
    Kyprianou N; English HF; Isaacs JT
    Cancer Res; 1990 Jun; 50(12):3748-53. PubMed ID: 2340521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of AP-1 activity by androgen activation of the androgen receptor in LNCaP human prostate carcinoma cells.
    Church DR; Lee E; Thompson TA; Basu HS; Ripple MO; Ariazi EA; Wilding G
    Prostate; 2005 May; 63(2):155-68. PubMed ID: 15486991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells.
    Lin J; Adam RM; Santiestevan E; Freeman MR
    Cancer Res; 1999 Jun; 59(12):2891-7. PubMed ID: 10383151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of Egr-1 expression by the retinoid AHPN in human lung carcinoma cells is dependent on activated ERK1/2.
    Sakaue M; Adachi H; Dawson M; Jetten AM
    Cell Death Differ; 2001 Apr; 8(4):411-24. PubMed ID: 11550093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells.
    Ghafar MA; Anastasiadis AG; Chen MW; Burchardt M; Olsson LE; Xie H; Benson MC; Buttyan R
    Prostate; 2003 Jan; 54(1):58-67. PubMed ID: 12481256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staurosporine induces protein kinase C agonist effects and maturation of normal and neoplastic mouse keratinocytes in vitro.
    Dlugosz AA; Yuspa SH
    Cancer Res; 1991 Sep; 51(17):4677-84. PubMed ID: 1678684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.